Yellow Fever Vaccine Global Market Report 2025

Description

The yellow fever vaccine is a live, attenuated viral vaccine used to prevent yellow fever, a serious viral infection transmitted by mosquitoes. It is typically administered as a single dose and provides long-lasting immunity, often lifelong. The vaccine is crucial for individuals residing in or traveling to areas where yellow fever is endemic.

The main presentations of the yellow fever vaccine include powder and liquid forms. Yellow fever vaccine powder is lyophilized (freeze-dried), requiring reconstitution with a specific diluent before administration to confer immunity against the yellow fever virus. This vaccine is utilized for routine immunization, travelers' vaccinations, and other applications, and is distributed through various channels including hospitals, diagnostic centers, and point-of-care facilities.

The yellow fever vaccine market research report is one of a series of new reports from The Business Research Company that provides yellow fever vaccine market statistics, including yellow fever vaccine industry global market size, regional shares, competitors with a yellow fever vaccine market share, detailed yellow fever vaccine market segments, market trends and opportunities, and any further data you may need to thrive in the yellow fever vaccine industry. This yellow fever vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The yellow fever vaccine market size has grown strongly in recent years. It will grow from $4.54 billion in 2024 to $4.79 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to the initiation of global immunization campaigns, implementation of international health regulations, mass vaccination campaigns, and advances in vaccine production technology.

The yellow fever vaccine market size is expected to see strong growth in the next few years. It will grow to $5.84 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to increased collaboration and partnerships, integration with routine vaccination schedules, surveillance and monitoring, increasing involvement of the private sector, and adoption of digital technologies for vaccine tracking. Major trends in the forecast period include diversification of vaccine formats, pandemic preparedness, regulatory changes, healthcare infrastructure improvements, consumer education and awareness.

The yellow fever vaccine market is poised for growth driven by increasing international travel. International travel involves the movement of individuals across borders for tourism, business, or personal reasons and is on the rise due to enhanced global connectivity, economic expansion, and eased travel restrictions post-pandemic. The yellow fever vaccine is crucial for travelers visiting regions where yellow fever is endemic to prevent infection and comply with international health guidelines. For example, the World Tourism Organization reported in January 2024 that global international tourists (overnight visitors) reached 1.286 billion in 2023, marking a significant increase from 960 million in 2022. This surge highlights the growing demand for the yellow fever vaccine.

Leading companies in the yellow fever vaccine market are concentrating on developing advanced next-generation vaccines, such as the T-cell adaptive booster vaccine, to meet the rising global demand for vaccines. The T-cell adaptive booster vaccine is designed to enhance the immune system's memory T-cell response, ensuring prolonged and robust immunity against specific pathogens. For instance, Emergex Vaccines Holding Limited, a UK-based biotechnology company, partnered with ATCC, a US-based non-profit organization, in April 2022 to introduce CD8+ T-cell adaptive vaccines tailored for yellow fever. These vaccines stimulate a potent cytotoxic T-cell response critical for identifying and eliminating virus-infected cells. By promoting memory CD8+ T-cell production, these vaccines provide durable protection against yellow fever by focusing on cellular immunity, complementing traditional antibody-based approaches.

In October 2022, Emergex Vaccines Holding Limited expanded its capabilities by acquiring the assets of Zosano Pharma Corporation, a US-based pharmaceutical company specializing in transdermal delivery systems. This acquisition strengthens Emergex Vaccines' vaccine delivery methods, enhancing its ability to develop and commercialize innovative vaccines, including those targeting yellow fever.

Major companies operating in the yellow fever vaccine market are Merck and Co Inc., Sanofi S.A., GSK plc, Takeda Pharmaceutical Company, Lonza Group Ag, WuXi Biologics, Novavax Inc., Beijing Tiantan Biological, Bavarian Nordic A/S, Valneva SE, Biological E. Limited, Bio-Manguinhos, Instituto Butantan, Bio Farma, Panacea Biotec, Biovac, Institut Pasteur de Dakar, Ology Bioservices, Gavi, Wuhan Institute of Biological Products, PnuVax Incorporated, iBio Inc.

North America was the largest region in the yellow fever vaccine market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yellow fever vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the yellow fever vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The yellow fever vaccine market consists of sales of vaccine syringes, needles, and vaccine storage equipment. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Yellow Fever Vaccine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on yellow fever vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for yellow fever vaccine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The yellow fever vaccine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product: Powder; Liquid
2) By Treatment Type: Pain Management Drugs; Oral Rehydration
3) By Application: Routine Immunization; Travelers; Other Applications
4) By End-User: Hospitals; Diagnostic Centers; Point Of Care Centers; Other End Users
Subsegments:
1) By Powder: Lyophilized Powder For Reconstitution; Freeze-Dried Powder For Reconstitution
2) By Liquid: Ready-To-Use Liquid Vaccine; Liquid Vaccine In Pre-Filled Syringes
Companies Mentioned: Merck and Co Inc.; Sanofi S.A.; GSK plc; Takeda Pharmaceutical Company; Lonza Group Ag
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r31555

1. Executive Summary

2. Yellow Fever Vaccine Market Characteristics

3. Yellow Fever Vaccine Market Trends And Strategies

4. Yellow Fever Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Yellow Fever Vaccine Growth Analysis And Strategic Analysis Framework

5.1. Global Yellow Fever Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Yellow Fever Vaccine Market Growth Rate Analysis
5.4. Global Yellow Fever Vaccine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Yellow Fever Vaccine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Yellow Fever Vaccine Total Addressable Market (TAM)

6. Yellow Fever Vaccine Market Segmentation

6.1. Global Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Powder
Liquid
6.2. Global Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pain Management Drugs
Oral Rehydration
6.3. Global Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Routine Immunization
Travelers
Other Applications
6.4. Global Yellow Fever Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Diagnostic Centers
Point Of Care Centers
Other End Users
6.5. Global Yellow Fever Vaccine Market, Sub-Segmentation Of Powder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lyophilized Powder For Reconstitution
Freeze-Dried Powder For Reconstitution
6.6. Global Yellow Fever Vaccine Market, Sub-Segmentation Of Liquid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ready-To-Use Liquid Vaccine
Liquid Vaccine In Pre-Filled Syringes

7. Yellow Fever Vaccine Market Regional And Country Analysis

7.1. Global Yellow Fever Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Yellow Fever Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Yellow Fever Vaccine Market

8.1. Asia-Pacific Yellow Fever Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Yellow Fever Vaccine Market

9.1. China Yellow Fever Vaccine Market Overview
9.2. China Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Yellow Fever Vaccine Market

10.1. India Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Yellow Fever Vaccine Market

11.1. Japan Yellow Fever Vaccine Market Overview
11.2. Japan Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Yellow Fever Vaccine Market

12.1. Australia Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Yellow Fever Vaccine Market

13.1. Indonesia Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Yellow Fever Vaccine Market

14.1. South Korea Yellow Fever Vaccine Market Overview
14.2. South Korea Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Yellow Fever Vaccine Market

15.1. Western Europe Yellow Fever Vaccine Market Overview
15.2. Western Europe Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Yellow Fever Vaccine Market

16.1. UK Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Yellow Fever Vaccine Market

17.1. Germany Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Yellow Fever Vaccine Market

18.1. France Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Yellow Fever Vaccine Market

19.1. Italy Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Yellow Fever Vaccine Market

20.1. Spain Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Yellow Fever Vaccine Market

21.1. Eastern Europe Yellow Fever Vaccine Market Overview
21.2. Eastern Europe Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Yellow Fever Vaccine Market

22.1. Russia Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Yellow Fever Vaccine Market

23.1. North America Yellow Fever Vaccine Market Overview
23.2. North America Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Yellow Fever Vaccine Market

24.1. USA Yellow Fever Vaccine Market Overview
24.2. USA Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Yellow Fever Vaccine Market

25.1. Canada Yellow Fever Vaccine Market Overview
25.2. Canada Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Yellow Fever Vaccine Market

26.1. South America Yellow Fever Vaccine Market Overview
26.2. South America Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Yellow Fever Vaccine Market

27.1. Brazil Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Yellow Fever Vaccine Market

28.1. Middle East Yellow Fever Vaccine Market Overview
28.2. Middle East Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Yellow Fever Vaccine Market

29.1. Africa Yellow Fever Vaccine Market Overview
29.2. Africa Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Yellow Fever Vaccine Market Competitive Landscape And Company Profiles

30.1. Yellow Fever Vaccine Market Competitive Landscape
30.2. Yellow Fever Vaccine Market Company Profiles
- 30.2.1. Merck and Co Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. GSK plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Takeda Pharmaceutical Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Lonza Group Ag Overview, Products and Services, Strategy and Financial Analysis

31. Yellow Fever Vaccine Market Other Major And Innovative Companies

31.1. WuXi Biologics
31.2. Novavax Inc.
31.3. Beijing Tiantan Biological
31.4. Bavarian Nordic A/S
31.5. Valneva SE
31.6. Biological E. Limited
31.7. Bio-Manguinhos
31.8. Instituto Butantan
31.9. Bio Farma
31.10. Panacea Biotec
31.11. Biovac
31.12. Institut Pasteur de Dakar
31.13. Ology Bioservices
31.14. Gavi
31.15. Wuhan Institute of Biological Products

32. Global Yellow Fever Vaccine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Yellow Fever Vaccine Market

34. Recent Developments In The Yellow Fever Vaccine Market

35. Yellow Fever Vaccine Market High Potential Countries, Segments and Strategies

35.1 Yellow Fever Vaccine Market In 2029 - Countries Offering Most New Opportunities
35.2 Yellow Fever Vaccine Market In 2029 - Segments Offering Most New Opportunities
35.3 Yellow Fever Vaccine Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer